These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11441068)

  • 1. Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.
    Amrani A; Serra P; Yamanouchi J; Trudeau JD; Tan R; Elliott JF; Santamaria P
    J Immunol; 2001 Jul; 167(2):655-66. PubMed ID: 11441068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
    Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
    J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
    Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
    Judkowski V; Pinilla C; Schroder K; Tucker L; Sarvetnick N; Wilson DB
    J Immunol; 2001 Jan; 166(2):908-17. PubMed ID: 11145667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
    Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.
    Lieberman SM; Takaki T; Han B; Santamaria P; Serreze DV; DiLorenzo TP
    J Immunol; 2004 Dec; 173(11):6727-34. PubMed ID: 15557165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.
    Amrani A; Verdaguer J; Serra P; Tafuro S; Tan R; Santamaria P
    Nature; 2000 Aug; 406(6797):739-42. PubMed ID: 10963600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell cross-presentation of autologous antigen precipitates diabetes.
    Mariño E; Tan B; Binge L; Mackay CR; Grey ST
    Diabetes; 2012 Nov; 61(11):2893-905. PubMed ID: 22829452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.
    Amrani A; Verdaguer J; Anderson B; Utsugi T; Bou S; Santamaria P
    J Clin Invest; 1999 Apr; 103(8):1201-9. PubMed ID: 10207172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
    Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
    J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet-associated T-cell receptor-β CDR sequence repertoire in prediabetic NOD mice reveals antigen-driven T-cell expansion and shared usage of VβJβ TCR chains.
    Toivonen R; Arstila TP; Hänninen A
    Mol Immunol; 2015 Mar; 64(1):127-35. PubMed ID: 25480393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.
    Nikoopour E; Sandrock C; Huszarik K; Krougly O; Lee-Chan E; Masteller EL; Bluestone JA; Singh B
    J Immunol; 2011 Apr; 186(7):3831-5. PubMed ID: 21357258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience.
    Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV
    J Immunol; 2004 Sep; 173(6):3791-800. PubMed ID: 15356126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.